-
Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
- Aisling M Vaughan1,* , Mohammed Afzal2,* , Priyanka Nannapaneni2 , Mathias Leroy1 , Xanthi Andrianou2 , Jeffrey Pires1 , Silvia Funke2 , Celine Roman1 , Juliana Reyes-Uruena2 , Stephan Aberle3 , Aristos Aristodimou4 , Gudrun Aspelund5 , Kirsty F Bennet6 , Antra Bormane7 , Anna Caraglia8 , Hannah Charles6 , Emilie Chazelle9 , Iva Christova10 , Orna Cohen11 , Costas Constantinou4 , Simon Couvreur12 , Asuncion Diaz13 , Kateřina Fabiánová14 , Federica Ferraro8 , Marte Petrikke Grenersen15 , Eva Grilc16 , Tuula Hannila-Handelberg17 , Anne Kathrine Hvass18 , Derval Igoe19 , Klaus Jansen20 , Denisa Janță21 , Styliani Kaoustou22 , Anders Koch18,23 , Mirjana Lana Kosanovic Licina24 , Stefka Krumova10 , Anton Labutin25 , Raskit Lachmann20 , Amaryl Lecompte12 , Rémi Lefrançois26 , Viktorija Leitena7 , Kirsi Liitsola17 , Ivan Mlinarić27 , Zohar Mor11,28 , Martha Neary29 , Alina Novacek30 , Magnus Wenstøp Øgle15 , Hana Orlíková14,31 , Kalliopi Papadima22 , Moa Rehn32 , Malgorzata Sadkowska-Todys33 , Anca Sîrbu21 , Klara Sondén32 , Berta Suárez34 , Marianna Thordardottir5 , Paula Vasconcelos35 , Joao Vieira Martins36 , Karolina Zakrzewska33 , Marc-Alain Widdowson1,** , Céline M Gossner2,**
-
View Affiliations Hide AffiliationsAffiliations: 1 World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark 2 European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 3 Medical University of Vienna, Centre for Virology, Vienna, Austria 4 Medical and Public Health Services, Nicosia, Cyprus 5 Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland 6 United Kingdom Health Security Agency, London, United Kingdom 7 Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia 8 Ministry of Health, Rome, Italy 9 Santé publique France, the French National Public Health Agency, Saint-Maurice, France 10 National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria 11 Division of Epidemiology, Ministry of Health, Jerusalem, Israel 12 Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium 13 National Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain 14 National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia 15 Norwegian Institute of Public Health (NIPH), Oslo, Norway 16 NIJZ (NIPH), Centre for Communicable Diseases, Ljubljana, Slovenia 17 Finnish Institute for Health and Welfare, Helsinki, Finland 18 Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark 19 HSE Public Health: National Health Protection Office, Dublin, Ireland 20 Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany 21 National Institute of Public Health, Bucharest, Romania 22 Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece 23 Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark 24 Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia 25 Swiss Federal Office of Public Health, Bern, Switzerland 26 Santé publique France, the French National Public Health Agency, Saint-Denis, France 27 Croatian Institute of Public Health, Division for Epidemiology of Communicable Diseases, Zagreb, Croatia 28 School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel 29 HSE Health Protection Surveillance Centre, Dublin, Ireland 30 Austrian Agency for Health and Food Safety, Vienna, Austria 31 Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czechia 32 Public Health Agency of Sweden (PHAS), Solna, Sweden 33 National Institute of Public Health NIH - National Research Institute, Warsaw, Poland 34 Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain 35 Public Health Emergency Centre, Directorate-General of Health (DGS), Lisbon, Portugal 36 Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal * These authors contributed equally as first authors ** These authors contributed equally as last authorsAisling M. Vaughanvaughana who.int
-
View Citation Hide Citation
Citation style for this article: Vaughan Aisling M, Afzal Mohammed, Nannapaneni Priyanka, Leroy Mathias, Andrianou Xanthi, Pires Jeffrey, Funke Silvia, Roman Celine, Reyes-Uruena Juliana, Aberle Stephan, Aristodimou Aristos, Aspelund Gudrun, Bennet Kirsty F, Bormane Antra, Caraglia Anna, Charles Hannah, Chazelle Emilie, Christova Iva, Cohen Orna, Constantinou Costas, Couvreur Simon, Diaz Asuncion, Fabiánová Kateřina, Ferraro Federica, Grenersen Marte Petrikke, Grilc Eva, Hannila-Handelberg Tuula, Hvass Anne Kathrine, Igoe Derval, Jansen Klaus, Janță Denisa, Kaoustou Styliani, Koch Anders, Kosanovic Licina Mirjana Lana, Krumova Stefka, Labutin Anton, Lachmann Raskit, Lecompte Amaryl, Lefrançois Rémi, Leitena Viktorija, Liitsola Kirsi, Mlinarić Ivan, Mor Zohar, Neary Martha, Novacek Alina, Øgle Magnus Wenstøp, Orlíková Hana, Papadima Kalliopi, Rehn Moa, Sadkowska-Todys Malgorzata, Sîrbu Anca, Sondén Klara, Suárez Berta, Thordardottir Marianna, Vasconcelos Paula, Vieira Martins Joao, Zakrzewska Karolina, Widdowson Marc-Alain, Gossner Céline M. Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024. Euro Surveill. 2024;29(27):pii=2400330. https://doi.org/10.2807/1560-7917.ES.2024.29.27.2400330 Received: 30 May 2024; Accepted: 04 Jul 2024
Abstract
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
Article metrics loading...
Full text loading...
References
-
Vaughan AM, Cenciarelli O, Colombe S, Alves de Sousa L, Fischer N, Gossner CM, et al. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill. 2022;27(36):2200620. https://doi.org/10.2807/1560-7917.ES.2022.27.36.2200620 PMID: 36082686
-
World Health Organization (WHO). Standing recommendations for mpox issued by the Director-General of the World Health Organization (WHO) in accordance with the International Health Regulations (2005) (IHR). Geneva: WHO; 2023. Available from: https://www.who.int/publications/m/item/standing-recommendations-for-mpox-issued-by-the-director-general-of-the-world-health-organization-(who)-in-accordance-with-the-international-health-regulations-(2005)-(ihr)
-
Delaney KP, Sanchez T, Hannah M, Edwards OW, Carpino T, Agnew-Brune C, et al. Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission - United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(35):1126-30. https://doi.org/10.15585/mmwr.mm7135e1 PMID: 36048582
-
Brand SPC, Cavallaro M, Cumming F, Turner C, Florence I, Blomquist P, et al. The role of vaccination and public awareness in forecasts of Mpox incidence in the United Kingdom. Nat Commun. 2023;14(1):4100. https://doi.org/10.1038/s41467-023-38816-8 PMID: 37433797
-
Murayama H, Pearson CAB, Abbott S, Miura F, Jung SM, Fearon E, et al. Accumulation of immunity in heavy-tailed sexual contact networks shapes mpox outbreak sizes. J Infect Dis. 2024;229(1):59-63. https://doi.org/10.1093/infdis/jiad254 PMID: 37402631
-
Xiridou M, Miura F, Adam P, Op de Coul E, de Wit J, Wallinga J. The fading of the mpox outbreak among men who have sex with men: a mathematical modelling study. J Infect Dis. 2023;jiad414. https://doi.org/10.1093/infdis/jiad414 PMID: 37740556
-
Haverkate MR, Willemstein IJ, van Ewijk CE, Adam PC, Lanooij SJ, Jonker-Jorna P, et al. Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023. Euro Surveill. 2024;29(21):2300608. https://doi.org/10.2807/1560-7917.ES.2024.29.21.2300608 PMID: 38785092
-
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401(10380):939-49. https://doi.org/10.1016/S0140-6736(23)00273-8 PMID: 36828001
-
Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023;29(3):748-52. https://doi.org/10.1038/s41591-023-02229-3 PMID: 36720271
-
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med. 2023;388(26):2434-43. https://doi.org/10.1056/NEJMoa2215201 PMID: 37199451
-
Dalton AF, Diallo AO, Chard AN, Moulia DL, Deputy NP, Fothergill A, et al. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study - United States, August 19, 2022-March 31, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(20):553-8. https://doi.org/10.15585/mmwr.mm7220a3 PMID: 37200229
-
Rosenberg ES, Dorabawila V, Hart-Malloy R, Anderson BJ, Miranda W, O’Donnell T, et al. Effectiveness of JYNNEOS vaccine against diagnosed mpox infection - New York, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(20):559-63. https://doi.org/10.15585/mmwr.mm7220a4 PMID: 37339074
-
Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23(7):828-35. https://doi.org/10.1016/S1473-3099(23)00057-9 PMID: 36924787
-
European Centre for Disease Prevention and Control (ECDC). Implications for the EU/EEA of the outbreak of mpox caused by Monkeypox virus clade I in the Democratic Republic of the Congo. Stockholm: ECDC; 2023; Available from: https://www.ecdc.europa.eu/en/publications-data/implications-eueea-outbreak-mpox-caused-monkeypox-virus-clade-i-democratic
-
Kibungu EM, Vakaniaki EH, Kinganda-Lusamaki E, Kalonji-Mukendi T, Pukuta E, Hoff NA, et al. Clade I-associated mpox cases associated with sexual contact, the Democratic Republic of the Congo. Emerg Infect Dis. 2024;30(1):172-6. https://doi.org/10.3201/eid3001.231164 PMID: 38019211
-
World Health Organization Regional Office for Europe (WHO/Europe). Considerations for the control and elimination of mpox in the WHO European Region update 25 April 2023: the need for integrated national operational plans. Copenhagen: WHO/Europe; 2023. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2023-6007-45772-69163
-
World Health Organization (WHO). Mpox strategic preparedness, readiness, and response plan: global monitoring and evaluation framework. Geneva: WHO; 2022. Available from: https://www.who.int/publications/m/item/mpox-strategic-preparedness--readiness--and-response-plan
-
World Health Organization (WHO). Strategic framework for enhancing prevention and control of mpox- 2024-2027. Geneva: WHO; 2024. Available from: https://www.who.int/publications/i/item/9789240092907
Data & Media loading...
Supplementary data
-
-
Supplement
-